Andere talen Adial Pharmaceuticals, Inc.

Aandelen

ADIL

US00688A2050

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 21-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1,4 ^USD	-6,64%		-2,78%	-24,73%

22/04	Adial Pharmaceuticals verkrijgt Amerikaans octrooi voor een combinatie van genetische diagnostica en AD04 voor de behandeling van alcoholstoornissen	MT
12/04	Top premarket dalers	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Adial Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update	15/05
Adial Pharmaceuticals Granted US Patent for Genetic Diagnostic, AD04 Combination to Treat Alcohol Use Disorder	22/04
Adial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark Office	22/04
Top Premarket Decliners	12/04
Top Midday Gainers	10/04
Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use Disorder	10/04
Adial Pharmaceuticals, Inc Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use Disorder	10/04
Adial Pharmaceuticals Reports 2023 Fiscal Year Financial Results and Provides Business Update	02/04
Adial Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	01/04
Adial Pharmaceuticals, Inc. announced that it has received $0.2875 million in funding	14/03
Adial Pharmaceuticals, Inc. announced that it expects to receive $0.2875 million in funding	06/03
Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross Proceeds	04/03
Top Premarket Decliners	04/03
Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross Proceeds	02/03
Investors Await Key Economic Data, Markets Remain Flat Ahead of Opening Bell	01/03
US Futures Remain Flat as Investors Await Raft of Economic Data	01/03
Top Midday Gainers	28/02
Adial Pharmaceuticals Awarded New Patent from the United States Patent and Trademark Office	28/02
Adial Pharmaceuticals Secures US Patent Allowance for AD04, Genetic Diagnostic Combination	13/02
Adial Pharmaceuticals Awarded New Patent Notice of Allowance from the United States Patent and Trademark Office	13/02

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Adial Pharmaceuticals, Inc.

Aandelen

ADIL

US00688A2050

Andere talen

Filters